Cogent Biosciences, Inc. — Director's Dealing 2022

Jan 27, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cogent Biosciences, Inc. (COGT)
CIK: 0001622229
Period of Report: 2022-01-25

Reporting Person: Robinson John Edward (Chief Scientific Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-01-25	Stock Option (Right to Buy)	$7.60	A	250000	Acquired	2032-01-25	Common Stock (250000)	Direct

Footnotes

F1: This stock option shall vest in equal monthly installments over a four year period.